Mice with complete disruption of BRCA1 |
MGI:1858108 |
Brca1 <tm1Mak> |
Brca1Δ5-6
|
Die before E7.5 |
[35] |
MGI:2429692 |
Brca1 <tm2Mak> |
Brca1flox5-6
|
Conditional, viable |
[38] |
MGI:3762184 |
Brca1 <tm1.1Brn> |
Brca1Δ5-13
|
Embryonic lethal, embryonic development not analyzed |
[39] |
MGI:3696057 |
Brca1 <tm1Brn> |
Brca1flox5-13
|
Conditional, viable |
[39] |
Mice with Exon11 disruptions |
|
|
|
MGI:1857931 |
Brca1 <tm1Bhk> |
Brca1Δ223-763
|
Die between E8.5 to E13.5 |
[40] |
MGI:1930612 |
Brca1 <tm1Cxd> |
Brca111−
|
Die between E7.5 and E9.5 |
[42] |
MGI:1858107 |
Brca1 <tm1Whl> |
Brca1Δ300-361
|
Die before E7.5 |
[43] |
MGI:2177209 |
Brca1 <tm2Arge> |
Brca1tr
|
Largely viable, viability depends on genetic background |
[44] |
MGI:2182470 |
Brca1 <tm2.1Cxd> |
Brca1Δ11
|
Seldomly viable, most die between E12.5–18.5 |
[45] |
MGI:1931238 |
Brca1 <tm2Cxd> |
Brca1flox11
|
Conditional, viable |
[45] |
MGI:3665173 |
Brca1 <tm4Cxd> |
Brca1FL
|
Viable |
[47] |
Mice with RING domain disruptions |
|
|
MGI:1930613 |
Brca1 <tm1Arge> |
Brca1ex2
|
Die between E6.5 and E9.5 |
[48] |
MGI:3790741 |
Brca1 <tm1Thl> |
Brca1flex2
|
Conditional, viable |
[49] |
MGI:5823771 |
Brca1 <tm2Jjon> |
Brca1185stop
|
Die between E9.5 to E13.5 |
[50] |
MGI:5307254 |
Brca1 <tm1.1Jjon> |
Brca1C61G
|
Die between E9.5 and E12.5 |
[51] |
MGI:5494435 |
Brca1 <tm3.1Thl> |
Brca1I26A
|
Viable |
[41] |
Mice with BRCT domain disruptions |
|
|
MGI:2178447 |
Brca1 <tm1Rfo> |
Brca11700T
|
Die between E9.5 and E10.5 |
[53] |
MGI:5823772 |
Brca1 <tm3Jjon> |
Brca15382stop
|
Die between E9.5 and E12.5 |
[50] |
MGI:3706167 |
Brca1 <tm1Aash> |
Brca1F22-24
|
Conditional, viable |
[54] |
MGI:6281370 |
Brca1 <em1Njo> |
Brca1ΔC
|
Embryonic lethal, embryonic development not analyzed |
[56] |
MGI:5494434 |
Brca1 <tm2.1Thl> |
Brca1S1598F
|
Viable |
[41] |
Mice with disrupted phosphorylation |
|
|
MGI:3513253 |
Brca1 <tm3Cxd> |
Brca1S971A
|
Viable |
[61] |
MGI:4418211 |
Brca1 <tm5.1Cxd> |
Brca1S1152A
|
Viable |
[62] |